ARTICLE
20 March 2024

Recap And Key Insights From Record Cases: Delaware 2023 Litigation (Video)

BI
Buchanan Ingersoll & Rooney PC

Contributor

With 450 attorneys and government relations professionals across 15 offices, Buchanan Ingersoll & Rooney provides progressive legal, business, regulatory and government relations advice to protect, defend and advance our clients’ businesses. We service a wide range of clients, with deep experience in the finance, energy, healthcare and life sciences industries.
In 2023, the Delaware courts made significant decisions implicating different areas of intellectual property (IP) and corporate law. These rulings addressed topics such as induced infringement...
United States Delaware Intellectual Property

In 2023, the Delaware courts made significant decisions implicating different areas of intellectual property (IP) and corporate law. These rulings addressed topics such as induced infringement of drug patents, special purpose acquisition company (SPAC) transactions, inter partes reviews (IPRs), and litigation funding disclosures.

In the recorded presentation, we review these rulings, anticipate their impact on future proceedings, and closely monitor developments in this year's cases.

Watch the video here or below:

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More